PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 32 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $287,869 | +103.4% | 173,415 | +145.1% | 0.00% | – |
| Q2 2023 | $141,528 | +172495.1% | 70,764 | +181346.2% | 0.00% | – |
| Q1 2023 | $82 | -98.0% | 39 | -98.7% | 0.00% | – |
| Q4 2022 | $4,065 | +35.5% | 2,967 | -2.0% | 0.00% | – |
| Q3 2022 | $3,000 | -25.0% | 3,027 | -13.6% | 0.00% | – |
| Q2 2022 | $4,000 | -20.0% | 3,504 | -32.0% | 0.00% | – |
| Q1 2022 | $5,000 | -64.3% | 5,153 | -70.4% | 0.00% | – |
| Q4 2021 | $14,000 | +16.7% | 17,387 | +95.6% | 0.00% | – |
| Q3 2021 | $12,000 | +9.1% | 8,890 | +51.4% | 0.00% | – |
| Q2 2021 | $11,000 | -64.5% | 5,873 | -14.5% | 0.00% | – |
| Q1 2021 | $31,000 | +3000.0% | 6,870 | +2994.6% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 222 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 222 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | – | 222 | +616.1% | 0.00% | – |
| Q1 2020 | $0 | – | 31 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 2,470,332 | $8,967,000 | 6.83% |
| Psagot Value Holdings Ltd. | 470,255 | $1,707,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 212,591 | $772,000 | 0.02% |
| UBS OCONNOR LLC | 150,000 | $544,000,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 10,042 | $36,000 | 0.01% |
| Renaissance Technologies | 488,634 | $1,774,000 | 0.00% |
| Squarepoint Ops LLC | 22,068 | $80,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 222 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 50,280 | $183,000 | 0.00% |